Lexie B3 vs Oticon Intent

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.

The Oticon Intent is a premium behind-the-ear prescription hearing aid released in 2024, priced at $4,898 and earning an A grade with a SoundScore of 4.8/5 in our lab testing. This places it at #4 among 39 prescription hearing aids tested, within the top 8% of its category. In our testing, the Intent demonstrates notable strengths in speech performance, scoring 0.54 points above the category average for speech in quiet and a substantial 0.95 points above average for speech in noise. Music streaming is a particular highlight, measuring 1.24 points above the category average with a strong 4.0/5 score. Feedback handling is excellent at 5.0/5, slightly exceeding the already-high category average. The primary limitation revealed in our testing is own-voice comfort, which scores 1.3/5—a low absolute score that falls 1.40 points below the category average. Users sensitive to the sound of their own voice may find this characteristic noticeable. This is a common trade-off in devices optimized for speech audibility. The Oticon Intent is well-suited for users prioritizing speech understanding across varied listening environments and high-quality audio streaming. It has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. Shoppers in this premium price tier may also consider the Phonak Sphere Infinio (#2) or the lower-priced Oticon Zeal, which offers strong performance at a reduced cost.